Gilenya ‘prevents activation of key immune cells’
Gilenya ‘prevents activation of key immune cells’
In a recent study entitled Myeloid Cells As Target Of Gilenya Action In Multiple Sclerosis, a team of scientists investigated the impact of MS treatment Gilenya on the reactivity of myeloid cells, a key group that comprises several immune cells that are activated in MS patients and the underlying cause of the condition. The study was published in the journal Neurology...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 3 Replies
- 4870 Views
-
Last post by NHE
-
- 5 Replies
- 13313 Views
-
Last post by gibbledygook
-
- 0 Replies
- 742 Views
-
Last post by DIM
-
- 0 Replies
- 842 Views
-
Last post by frodo
-
- 61 Replies
- 13393 Views
-
Last post by jimmylegs
-
- 1 Replies
- 1505 Views
-
Last post by ElliotB
-
- 0 Replies
- 1362 Views
-
Last post by Petr75
-
- 0 Replies
- 1965 Views
-
Last post by NHE
-
- 1 Replies
- 1097 Views
-
Last post by frodo